These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29567198)

  • 1. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic.
    Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A
    Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel lipid-coated mesoporous silica nanoparticles loaded with thymoquinone formulation to increase its bioavailability in the brain and organs of Wistar rats.
    Fahmy HM; Ahmed MM; Mohamed AS; Shams-Eldin E; Abd El-Daim TM; El-Feky AS; Mustafa AB; Abd Alrahman MW; Mohammed FF; Fathy MM
    BMC Pharmacol Toxicol; 2022 Sep; 23(1):71. PubMed ID: 36163187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
    Roggers RA; Lin VS; Trewyn BG
    Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
    Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
    Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
    Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect.
    Lin J; Cai Q; Tang Y; Xu Y; Wang Q; Li T; Xu H; Wang S; Fan K; Liu Z; Jin Y; Lin D
    Int J Pharm; 2018 Jan; 536(1):272-282. PubMed ID: 29079221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
    Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
    Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Fusion Mediated Intracellular Delivery of Lipid Bilayer Coated Mesoporous Silica Nanoparticles.
    Yang J; Tu J; Lamers GEM; Olsthoorn RCL; Kros A
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28945015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on pH-sensitive lipid bilayer-coated mesoporous silica nanoparticles as a novel drug carrier for antitumor drug].
    Li FF; Zhang XX; Guo SY; Gan Y; Li J
    Yao Xue Xue Bao; 2013 Feb; 48(2):291-7. PubMed ID: 23672029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Liu G; Zheng D; Tian X
    Int J Pharm; 2013 Mar; 445(1-2):12-9. PubMed ID: 23384728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
    Mai Z; Chen J; Hu Y; Liu F; Fu B; Zhang H; Dong X; Huang W; Zhou W
    J Colloid Interface Sci; 2017 Dec; 508():184-195. PubMed ID: 28841476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved controlled release of protein from expanded-pore mesoporous silica nanoparticles modified with co-functionalized poly(n-isopropylacrylamide) and poly(ethylene glycol) (PNIPAM-PEG).
    Yu E; Lo A; Jiang L; Petkus B; Ileri Ercan N; Stroeve P
    Colloids Surf B Biointerfaces; 2017 Jan; 149():297-300. PubMed ID: 27776334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.
    Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
    Theranostics; 2017; 7(3):523-537. PubMed ID: 28255347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
    Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
    Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.